Hydrochloric Acid

Hydrochloric Acid

SCHEMBL692717

CONO.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1040961 0.95
Hydrochloric Acid SCHEMBL9241831 0.72
SCHEMBL16168160 0.68
SCHEMBL1275386 0.65
SCHEMBL31195948 0.65
SCHEMBL10847922 0.64
Hydrochloric Acid SCHEMBL9538 0.63
Hydrochloric Acid SCHEMBL9938996 0.63
Methoxymethane SCHEMBL11651360 0.63
Hydrochloric Acid SCHEMBL1500349 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109956941-A A kind of simple and convenient process for preparing of AVM hereinafter Batan 新发药业有限公司 2019-07-02 CN claimed
CN-106890623-A Seawater uranium extraction adsorbent with antibacterial performance and preparation method thereof 中国工程物理研究院核物理与化学研究所 2017-06-27 CN claimed
US-12378234-B2 Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative BANTAM PHARMACEUTICAL, LLC (US) 2025-08-05 US disclosed
US-12150934-B2 Methods of using substituted pyrazole and pyrazole compounds and for treatment of hyperproliferative diseases BANTAM PHARMACEUTICAL, LLC (US) 2024-11-26 US disclosed
CN-118930533-A Substituted pyrazole compounds and methods of using the same for treating hyperproliferative diseases 班塔姆制药有限责任公司 2024-11-12 CN disclosed
CN-118330228-A Method for characterizing histidine nucleophilic reaction activity 中国科学院大连化学物理研究所 2024-07-12 CN disclosed
US-20240140934-A1 TRIAZOLE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF Shenzhen Jikang Pharmaceutical Technology Co., Ltd. (CN) 2024-05-02 US disclosed
CN-110603254-B Substituted pyrazole compounds and methods of using the same for treating hyperproliferative diseases 班塔姆制药有限责任公司 2024-04-12 CN disclosed
EP-4306517-A1 TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shenzhen Jikang Pharmaceutical Technology Co., Ltd. (CN) 2024-01-17 EP disclosed
CN-115505018-B Fusidic acid derivative with anti-inflammatory activity and preparation method and application thereof 烟台大学 2023-10-24 CN disclosed
CN-116897153-A Triazole derivative and preparation method and application thereof 深圳济康医药科技有限公司 2023-10-17 CN disclosed
EP-0141204-B1 HYDROXYETHYL AZOLE DERIVATIVES BAYER AG (DE) 1990-05-02 EP disclosed
US-4918093-A CEREALS, RICE BAYER AKTIENGESELLSCHAFT (DE) 1990-04-17 US disclosed
EP-0176998-B1 ANTIMYCOTIC AGENT BAYER AG (DE) 1989-11-08 EP disclosed
US-4843088-A FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-06-27 US disclosed
US-4843089-A HYDROXYETHYL-AZOLES BAYER AKTIENGESELLSCHAFT (DE) 1989-06-27 US disclosed
EP-0301349-A1 Hydroxyethyl-azolyl oximethers BAYER AG (DE) 1989-02-01 EP disclosed
US-4647457-A Penicillanic acid derivatives HOFFMANN-LA ROCHE INC. (US) 1987-03-03 US disclosed
US-4645767-A FOR PLANTS BAYER AKTIENGESELLSCHAFT (DE) 1987-02-24 US disclosed
EP-0176998-A2 Antimycotic agent BAYER AG (DE) 1986-04-09 EP disclosed